Home
Litigation

Work Area: Litigation

Janssen’s latest move against Amgen highlights shifting pharma patent strategies

J&J subsidiary makes innovative use of IP acquired in $6.5 billion Momenta acquisition

Blackberry patent buyer’s US litigation track record

Key Patent Innovations has a scant history of suing in the States, indicating its licensing approach may centre on private negotiations in contrast to the failed purchaser

Ericsson and Nokia v Oppo signal that non-discriminatory terms are key concern for Indian courts

Recent case law, along with the trend for out-of-court settlements between SEP holders and mobile manufacturers, highlights that the non-discriminatory part of ‘FRAND’ is being treated as a priority right now.

Latest content

Key US rulings that patent technical experts must know in 2023

If they are to win US patent assertions, rights holders must ensure the technology experts whom they rely upon to prove infringement and validity are minding significant 2022 rulings

13 January 2023

Xiaomi inks ‘unique’ multi-lateral licensing deal with IP Bridge, Orange and Siemens

Former company Head of IP Strategy worked as the facilitator for agreements that cover a range of technologies

11 January 2023

Qualcomm must face consumers’ antitrust claims

Cell phone purchasers can pursue claims that Qualcomm closed off the market via exclusive contracts, yet the attack has failed against its “no licence, no chip” policy

10 January 2023

Patent cases before US district courts drop in 2022

Docket Navigator data indicates patent filings decreased the most in Delaware and West Texas – but Eastern Texas got a slight bump

09 January 2023

Novartis $245 million pay-out is latest reminder of pay-for-delay risks

Patent litigation settlements face increasingly dangerous antitrust pitfalls

09 January 2023

Apple’s ex-licensing director alleges patent department favours white men

Jayna Whitt’s wrongful termination suit against the iPhone maker claims that women and minority patent professionals do not receive the same career opportunities

05 January 2023

Patent litigation finance booming while insurance market evolving, providers say

Industry practitioners remain optimistic against an unstable financial backdrop

04 January 2023

Four developments to watch out for in the mRNA patent wars this year

Disputes over vaccine technology will continue to occupy headlines in 2023

03 January 2023

ITC transparency trend highlights best practices for filing complaints

The US International Trade Commission recently started releasing letters to complainants about non-institution decisions – sign-posting to counsel how to better plead cases in 2023

03 January 2023

Brazilian patent term decision quashed and other 2022 Latin America developments

IAM looks back at some key stories from Brazil and Colombia over the last 12 months

29 December 2022

Unlock unlimited access to all IAM content